101. Resveratrol increases resistance of mouse oocytes to postovulatory aging in vivo
- Author
-
Yi-Hua Lin, Liang Zhou, Qiu-Xia Liang, Chun-Hui Zhang, Wei-Ping Qian, Heide Schatten, Hong-Mei Sun, and Qing-Yuan Sun
- Subjects
Ovulation ,0301 basic medicine ,Aging ,Oxidative phosphorylation ,resveratrol ,Mitochondrion ,Resveratrol ,medicine.disease_cause ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Sirtuin 1 ,In vivo ,medicine ,Animals ,oocyte ,skin and connective tissue diseases ,Cellular Senescence ,Mice, Inbred ICR ,postovulatory aging ,biology ,Cell Biology ,Oocyte ,Cell biology ,Oxidative Stress ,030104 developmental biology ,medicine.anatomical_structure ,Gene Expression Regulation ,chemistry ,Apoptosis ,030220 oncology & carcinogenesis ,Oocytes ,biology.protein ,Female ,Reactive Oxygen Species ,Oxidative stress ,Research Paper - Abstract
After ovulation, metaphase II oocytes undergo a time-dependent deterioration in vivo or in vitro, which is referred to as postovulatory oocyte aging, a process during which a series of deleterious molecular and cellular changes occur. In this study, we found that short-term injection of resveratrol (3,5,4'-trihydroxystilbene) effectively ameliorated oxidative stress-induced damage in postovulatory oocyte aging of middle-aged mice in vivo. Resveratrol induced changes that delayed the aging-induced oocyte deterioration including the elevated expression of the anti-aging molecule Sirtuin 1 (SIRT1); it reduced intracellular reactive oxygen species (ROS) level, and improved mitochondria function. In addition, these beneficial changes may also help to prevent apoptosis. Taken together, our data suggest that resveratrol can effectively protect against postovulatory oocyte aging in vivo primarily by preventing ROS production.
- Published
- 2018